These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1993008)

  • 1. The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.
    Weinberger DR; Gibson R; Coppola R; Jones DW; Molchan S; Sunderland T; Berman KF; Reba RC
    Arch Neurol; 1991 Feb; 48(2):169-76. PubMed ID: 1993008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
    Holman BL; Gibson RE; Hill TC; Eckelman WC; Albert M; Reba RC
    JAMA; 1985 Dec; 254(21):3063-6. PubMed ID: 3877181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies.
    Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia.
    Raedler TJ; Knable MB; Jones DW; Urbina RA; Gorey JG; Lee KS; Egan MF; Coppola R; Weinberger DR
    Am J Psychiatry; 2003 Jan; 160(1):118-27. PubMed ID: 12505810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
    Colloby SJ; Pakrasi S; Firbank MJ; Perry EK; Piggott MA; Owens J; Wyper DJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Neuroimage; 2006 Nov; 33(2):423-9. PubMed ID: 16959499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
    Pakrasi S; Colloby SJ; Firbank MJ; Perry EK; Wyper DJ; Owens J; McKeith IG; Williams ED; O'Brien JT
    J Neurol; 2007 Jul; 254(7):907-13. PubMed ID: 17361343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of cerebral muscarinic receptors with I-123 QNB and SPECT: studies in normal subjects and patients with dementia.
    Weinberger DR; Jones DW; Sunderland T; Lee KS; Sexton R; Gorey J; Reba R
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():194A-195A. PubMed ID: 1498808
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Ell PJ; Murphy DG
    Horm Behav; 2007 Feb; 51(2):249-57. PubMed ID: 17173920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Owens J; Ell PJ; Murphy DG
    Nucl Med Biol; 2004 Jul; 31(5):583-90. PubMed ID: 15219276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
    Boundy KL; Barnden LR; Rowe CC; Reid M; Kassiou M; Katsifis AG; Lambrecht RM
    J Nucl Med; 1995 Jul; 36(7):1332-8. PubMed ID: 7790964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
    Brown D; Chisholm JA; Owens J; Pimlott S; Patterson J; Wyper D
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):296-300. PubMed ID: 12552349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
    J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E; Franck G
    Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats.
    Knol RJ; de Bruin K; Opmeer B; Voorn P; Jonker AJ; van Eck-Smit BL; Booij J
    Nucl Med Biol; 2014 Jan; 41(1):90-5. PubMed ID: 24267055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
    McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF
    J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerning the distribution of cerebral muscarinic acetylcholine receptors in Alzheimer's disease.
    Zeeberg B
    Arch Neurol; 1991 Nov; 48(11):1117-8. PubMed ID: 1953390
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer.
    Eckelman WC; Eng R; Rzeszotarski WJ; Gibson RE; Francis B; Reba RC
    J Nucl Med; 1985 Jun; 26(6):637-42. PubMed ID: 3998853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
    Claus JJ; Dubois EA; Booij J; Habraken J; de Munck JC; van Herk M; Verbeeten B; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):602-8. PubMed ID: 9169565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.